| Pharmaceutical Information |
| Drug Name |
Tolazamide |
| Drug ID |
BADD_D02238 |
| Description |
A sulphonylurea hypoglycemic agent with actions and uses similar to those of chlorpropamide. |
| Indications and Usage |
For use as an adjunct to diet to lower the blood glucose in patients with non-insulin dependent diabetes mellitus (Type II) whose hyperglycemia cannot be satisfactorily controlled by diet alone. |
| Marketing Status |
approved; investigational |
| ATC Code |
A10BB05 |
| DrugBank ID |
DB00839
|
| KEGG ID |
D00379
|
| MeSH ID |
D014042
|
| PubChem ID |
5503
|
| TTD Drug ID |
D09FJB
|
| NDC Product Code |
Not Available |
| UNII |
9LT1BRO48Q
|
| Synonyms |
Tolazamide | Tolinase |
|
| Chemical Information |
| Molecular Formula |
C14H21N3O3S |
| CAS Registry Number |
1156-19-0 |
| SMILES |
CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN2CCCCCC2 |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
|
